Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Privitera Salvatore, Chief Technology Officer. Director active across 1 company, notably AtriCure, Inc.. Cumulatively, 18 filings have been recorded. Split: 1 buy · 6 sells. Total volume traded: €2.7m. Activity tracked since 30 June 2021. The latest transaction was filed on 1 March 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
171 shares@ US$45.720.0005% mcap0.2% of flowCommon StockSEC:0001209191-21-044923:0
18 of 18 declarations
About Privitera Salvatore
Salvatore Privitera is the Chief Technical Officer of AtriCure, Inc. In this role, he is responsible for the technical direction and innovation within the company. Privitera plays a key role in developing new technologies and medical solutions, contributing to improving AtriCure's products and services. His technical expertise is essential to support the company's mission.